Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-11 Sale | 2023-08-15 4:30 pm | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 29,302 | $4.1267 | $120,921 | 244,739 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-12 Exercise | 2024-03-14 4:17 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,720 | $0 | 527,316 (Direct) | View |
| 2024-03-12 Tax Withholding | 2024-03-14 4:17 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 30,790 | $5.31 | 527,316 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 5:40 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 1,703,704 | $0 | 1,703,704 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 5:39 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 1,703,704 | $0 | 1,703,704 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 138,826 | $0 | 1,296,960 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 49,280 | $5.47 | 1,296,960 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 527,778 | $0 | 1,296,960 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:54 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 60,871 | $0 | 647,848 (Direct) | View |
| 2024-03-03 Tax Withholding | 2024-03-05 4:54 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 18,030 | $5.47 | 647,848 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:54 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 430,557 | $0 | 647,848 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:40 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 120,316 | $0 | 1,036,672 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 4:40 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 60,781 | $5.47 | 1,036,672 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:40 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 458,334 | $0 | 1,036,672 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:35 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 111,060 | $0 | 1,061,260 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 4:35 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 56,316 | $5.47 | 1,061,260 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:35 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 430,557 | $0 | 1,061,260 (Direct) | View |
| 2024-02-27 Tax Withholding | 2024-02-29 4:26 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 16,556 | $5.71 | 259,846 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:26 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 31,663 | $0 | 259,846 (Direct) | View |
| 2024-02-27 Tax Withholding | 2024-02-29 4:25 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 18,670 | $5.71 | 336,922 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:25 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 35,620 | $0 | 336,922 (Direct) | View |
| 2024-01-01 Other | 2024-01-03 4:36 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 33,458,067 | $0 | 35,430,500 (Direct) | View |
| 2024-01-01 Gift | 2024-01-03 4:36 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 1,598,115 | $0 | 35,430,500 (Direct) | View |
| 2021-12-01 Other(A) | 2023-12-01 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director 10% Owner | 3,073,298 | $0 | 19,034,029 (Indirect) | View |
| 2023-11-07 Other | 2023-11-08 6:22 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Tushar Bhikhubhai 10% Owner | 53,578,209 | $0 | 107,156,418 (Indirect) | View |
| 2023-11-07 Other | 2023-11-08 6:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director 10% Owner | 17,497,336 | $0 | 48,256,423 (Indirect) | View |
| 2023-11-07 Other | 2023-11-08 6:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Dipan Member of 13D Group | 26,905,073 | $0 | 53,810,146 (Indirect) | View |
| 2023-11-07 Other | 2023-11-08 6:20 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 21,269,420 | $0 | 43,051,406 (Indirect) | View |
| 2023-11-07 Other | 2023-11-08 6:20 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 24,753,252 | $0 | 50,019,070 (Indirect) | View |
| 2023-07-30 Exercise | 2023-08-01 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director | 54,949 | $0 | 54,949 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-05 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 11,571 | $3.1 | 274,041 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 23,095 | $0 | 274,041 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director | 112,179 | $0 | 727,692 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director | 107,034 | $0 | 727,692 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director | 80,128 | $0 | 250,771 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director | 76,453 | $0 | 250,771 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director | 76,453 | $0 | 76,453 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 80,128 | $0 | 255,727 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 76,453 | $0 | 255,727 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director | 80,128 | $0 | 245,727 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director | 76,453 | $0 | 245,727 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director | 80,128 | $0 | 262,072 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director | 76,453 | $0 | 262,072 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 80,128 | $0 | 13,338,204 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 76,453 | $0 | 13,338,204 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director | 80,128 | $0 | 269,537 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director | 76,453 | $0 | 269,537 (Direct) | View |
| 2023-05-10 Exercise | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director | 80,128 | $0 | 300,771 (Direct) | View |
| 2023-05-09 Option Award | 2023-05-11 4:15 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director | 76,453 | $0 | 300,771 (Direct) | View |
| 2023-03-12 Exercise | 2023-03-14 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 87,719 | $0 | 468,560 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 36,232 | $0 | 979,126 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 18,064 | $1.92 | 979,126 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 550,458 | $0 | 979,126 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 45,289 | $0 | 1,117,065 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 688,074 | $0 | 1,117,065 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 733,944 | $0 | 733,944 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO 10% Owner | 733,944 | $0 | 733,944 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 39,251 | $0 | 976,602 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 19,685 | $1.92 | 976,602 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 596,331 | $0 | 976,602 (Direct) | View |
| 2023-03-03 Exercise | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 22,645 | $0 | 541,131 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 8,164 | $1.92 | 541,131 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 6:00 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 458,715 | $0 | 541,131 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 4:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 43,717 | $0 | 305,693 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 4:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 22,967 | $2.09 | 305,693 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 4:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 40,687 | $0 | 359,719 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 4:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 22,059 | $2.09 | 359,719 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 36,197 | $0 | 320,226 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 31,662 | $0 | 253,864 (Direct) | View |
| 2023-02-27 Tax Withholding | 2023-03-01 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 17,557 | $2.16 | 253,864 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 35,620 | $0 | 318,796 (Direct) | View |
| 2023-02-27 Tax Withholding | 2023-03-01 4:30 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 19,752 | $2.16 | 318,796 (Direct) | View |